A drug candidate developed by researchers at the University of Tennessee Health Science Center for advanced metastatic castration-resistant prostate cancer is now in its first clinical trial.
UTHSC’s drug candidate for advanced prostate cancer goes to first clinical trial
- Post author:
- Post published:November 6, 2023
- Post category:uncategorized